Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
P/E ratio for Progyny, Inc. (PGNY)
P/E ratio as of 2023: 56.95
According to Progyny, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 56.95. At the end of 2022 the company had a P/E ratio of 94.60.
P/E ratio history for Progyny, Inc. from 2017 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 56.95 |
| 2022 | 94.60 |
| 2021 | 68.22 |
| 2020 | 78.21 |
| 2019 | -267.72 |
| 2018 | 1966.86 |
| 2017 | -90.37 |